Khaled Azar 
If your SaaS business is growing 30% year over year, the math of waiting is not what you think. Private SaaS companies with growth above 30% command 6-7x ARR multiples in current transactions. That same company growing 12% two years later commands 3.5-4x. Your ARR may grow 50% during the wait. Your enterprise value may fall. That is not a hypothetical — we see this pattern in deal after deal.
The “one more year” decision is the most expensive mistake in lower middle market M&A. It feels rational in the moment. The data says otherwise.
Why Your Business Value Does Not Scale With Revenue
Buyers price trajectory, not milestones. When the trajectory changes, so does everything else.
Most founders carry a flawed mental model of valuation: if ARR grows 30%, the business is worth 30% more. That math holds only if the multiple stays constant. It will not.
Valuation multiples in the lower middle market are not fixed benchmarks applied to whatever revenue you show up with. They reflect competitive tension among buyers bidding on your future — specifically, your projected growth rate and the confidence they have in it. When growth decelerates, buyers project that trend forward and reprice accordingly.
The data from current transactions is stark. According to ClearlyAcquired’s 2025-2026 SaaS multiple analysis, private SaaS companies growing above 40% command 7-10x ARR. Companies with growth below 20% typically trade at 3-5x. That spread is the entire game. It is the difference between a life-changing exit and an underwhelming one on the same revenue base.
The current valuation range separating slow-growth from high-growth private SaaS companies in lower middle market transactions. Same business category. Radically different outcomes based on growth trajectory alone.
Your ARR multiple is a bet on your future growth. When growth slows, buyers reduce that bet — and the reduction often exceeds the revenue gain from waiting.
The Decay Curve: Modeling a $3M ARR Company Over 24 Months
The numbers are not dramatic. That is what makes them dangerous — the value erosion happens gradually, then suddenly.
Consider a bootstrapped SaaS company: $3M ARR, 30% YoY growth, 90% gross margins, net revenue retention of 107%, no customer concentration issues. Clean financials. This is a very buyable business in February 2026 and buyers know it.
Initial outreach suggests a value range of $17-21M — roughly 5.5-7x ARR, depending on process competitiveness. The founder’s response: “Let me hit $4M ARR first. One more year.”
Here is what the model shows if growth follows the typical deceleration curve for a maturing SaaS business:
| Decision Point | ARR | YoY Growth | Multiple Range | Estimated Value |
|---|---|---|---|---|
| Sell now (Year 0) | $3.0M | 30% | 6-7x | $18-21M |
| Wait 12 months | $3.9M | 20% | 5-6x | $19.5-23.4M |
| Wait 24 months | $4.7M | 12% | 3.5-4.5x | $16.5-21.2M |
At 12 months, the math looks marginally better if growth holds at 20% — a roughly 8-10% improvement in value. But at 24 months, ARR has grown 57% while the low end of the value range has actually fallen below the original quote. Two more years of running the company. More risk taken. Worse outcome on the floor.
The critical variable is the multiple. And the multiple is driven by the growth rate trajectory buyers see in the trailing 12-month data at the moment of closing — not your current month performance, not your projections, but what you can prove happened over the last year.
This connects directly to understanding what drives SaaS valuation multiples in 2026 — growth rate is the single most powerful lever, followed by net revenue retention and profitability.
ARR can grow 57% while enterprise value falls — when the multiple compresses faster than revenue grows. The waiting decision needs to model both variables, not just revenue.
The Process Time Problem Nobody Accounts For
The decision to sell and the wire hitting your account are separated by 9-12 months. Most founders forget to factor in this gap.
A well-run M&A sale process for a lower middle market company takes 6-9 months from mandate signing to closing. Some deals move faster with a known strategic buyer. Many stretch to 12 months with contested due diligence or complex deal structure negotiations.
What this means practically: the trailing 12-month growth rate buyers will price at closing is not your growth rate today. It is your growth rate over the 12 months that will have elapsed by the time diligence concludes and the deal closes.
If you start a process today with 30% trailing growth, buyers will anchor on that number. If you wait 12 more months to “get ready,” you may start the process with 20% trailing growth — and close 9 months after that at 14%. By the time the deal signs, the story buyers were pricing has already deteriorated. You sold a 14%-growth company at a 20%-growth-company price point — if you are lucky. More often, buyers recut the price in final negotiations to reflect what the trailing data actually shows.
The Deal We Could Not Save
We worked with a founder of a $3.2M ARR B2B SaaS company in the HR tech vertical. Growing 32% year over year, strong net revenue retention, profitable. The business was genuinely differentiated in a specific niche and buyers responded to it.
One strategic acquirer submitted a preliminary indication at 7x — over $22M. The founder passed. The plan was to hit $5M ARR, close one more fiscal year strong, and come back to market in a better position.
Eighteen months later, a well-funded competitor entered their niche with a subsidized pricing model. Churn increased. New logo acquisition slowed. Growth had fallen to 11%. ARR had reached $4.1M — not $5M — because gross revenue gains were being offset by elevated churn. The growth story was gone. The pipeline that once generated inbound buyer interest had gone quiet.
We reopened the process. Buyers still engaged. The final close: $4.1M ARR at 4x = $16.4M. Nearly $6M less than the preliminary indication the founder walked away from.
More than 18 additional months of running the company. More stress. More equity dilution risk. A worse outcome. The $5M ARR milestone was never reached. The 7x multiple was never seen again.
Preliminary indications are real price signals from the real market. When a credible strategic offers 7x, the decision to wait must be weighed against that concrete data point — not against an optimistic projection that may never materialize.
When to Actually Start the Process
Based on our experience across dozens of lower middle market SaaS transactions, three conditions need to be true simultaneously to start a sale process with maximum leverage:
- Trailing 12-month growth is 20% or above — and the trend has been consistent for at least two years, not an acceleration in the last few months masking a longer deceleration pattern. Buyers will look past a good recent quarter if the history shows a declining trend.
- You have 12+ months of runway in the current trajectory — meaning you can sustain or modestly grow revenue through a 9-12 month process without extraordinary effort, unusual churn risk, or a sales cycle that requires your constant personal involvement to close every deal.
- You are personally prepared — the process is demanding. Founders who are not ready psychologically tend to stall deals at critical moments. The time to resolve ambivalence about selling is before the process starts, not during it.
If all three conditions are true today, the process should start today. Not after next fiscal year closes. Not after you hit the next ARR milestone. Today. Because by the time you start a process and close a deal, you will be presenting the trailing data from the next 9-12 months — and you want that data to reflect your company at its peak, not on the slope down from it.
This is one of the core exit planning mistakes we see founders make — treating the start of the sale process as the end point of preparation, when it is actually the beginning of a 9-12 month window where your historical performance continues to matter.
This framework applies to bootstrapped and lightly funded SaaS businesses in the $1M-$15M ARR range targeting financial or strategic acquirers. Venture-backed companies, businesses in active fundraising, or companies with inbound strategic conversations already in progress have different timing dynamics.
If you want to model your specific scenario — growth rate, ARR, NRR, and the timing impact — start with the Livmo SaaS Valuation Calculator to get a baseline, then book a conversation to pressure-test the timing math against current buyer demand in your category.
Frequently Asked Questions
When is the best time to sell a business?
The best time to sell is when trailing 12-month growth is strong (20% or above), buyer appetite in your category is active, and you are personally ready for a 9-12 month process. In SaaS, the optimal window is defined by growth trajectory, not by hitting an ARR milestone. Starting the process while growth is strong gives buyers a compelling story to price — and gives you negotiating leverage that disappears once growth decelerates.
Does waiting to sell hurt valuation?
It depends on what happens during the wait. If growth accelerates and the multiple expands, waiting helps. In practice, growth rates in most lower-middle-market SaaS businesses decelerate over time as the easiest customer segments are captured, competition increases, and the founder’s energy compounds over years of execution. When the multiple compresses faster than revenue grows — which our data shows happens frequently after the 18-month mark — waiting destroys value even as ARR increases.
How long does it take to sell a business?
A well-run M&A process for a lower middle market company typically takes 6-9 months from signing an advisory mandate to closing. Some deals close faster with a known strategic buyer. Others stretch to 12 months or more with complex due diligence or deal structure negotiations. Founders should budget 9 months as a baseline and factor that timeline into their decision-making — the growth rate buyers will see at closing is the rate from 9-12 months after you start the process, not today’s rate.
Should I sell my business now or wait?
If growth is above 20%, the business is profitable or near-profitable, you have received credible inbound buyer interest, and you are personally ready — the risk of waiting likely exceeds the upside. The decision framework should not be “do I want more ARR?” but rather “what happens to my multiple if growth slows 30-40% during the waiting period?” Model both variables. The ARR gain from waiting is predictable and modest. The multiple compression from growth deceleration can be severe and fast.
Next Steps
The first step is not preparing for a sale. It is understanding what your business is worth in today’s market — and what the timing math says about your specific situation.
We will assess your SaaS metrics against current transaction benchmarks, model the value scenarios across different timing windows, and give you a data-driven read on your optimal exit window — not a generic answer, but one built on what buyers are actually paying for businesses like yours right now in Q1 2026.